Wang et al. advanced this concept using peptide-based supermolecular silk hydrogels co-delivering anti-PD1 antibodies, IL-15, and STING agonists, achieving tumor regression and overcoming monotherapy resistance [18]. This evidence concerns the gene STING1 and neoplasm.